Prof. Christine Allen
Dr. Pauric Bannigan
Dr. Riley Hickman
Intrepid Labs is revolutionizing drug formulation through its AI-driven robotic platform that accelerates pharmaceutical development from months to days.
The University of Toronto spinout combined machine learning and robotics to develop Valiant, its modular AI-driven robotic laboratory that autonomously selects, prepares, and analyzes drug formulations. Unlike traditional trial-and-error approaches, Intrepid’s platform screens vast formulation possibilities simultaneously, enabling the intentional design of delivery format, dosing frequency, and patient experience from day one.
Founded in 2023 by leading academics, Intrepid Labs has established partnerships with major global pharmaceutical companies and is developing proprietary delivery technologies for small molecules and biologics.
